Organizing Committee
- Javier Garau, Barcelona, ES
- Jordi Vila, Barcelona, ES
- Rob Willems, Utrecht, NL
Conference Objectives
The speakers will review, assess and debate the virulence, antimicrobial resistance, and the infections caused by enterococci as well as the rationale for currently recommended antibiotic therapy. In addition, the public health importance of animals as reservoirs for enterococci will be discussed. At the end of the conference, the participants should have an improved understanding of the ecology, epidemiology, virulence and infections caused by these microorganisms.
Conference Venue
Institut d’Estudis Catalans, Barcelona, ES
Location
Target Audience
Clinical microbiologists, infectious diseases specialists, veterinarians, epidemiologists and pharmacists who want to increase their knowledge on enterococci.
Conference Programme
No downloadable material of this conference has been released.
Wednesday, 18 November 2009
16:00 Chairmen’s introduction
16:15 Enterococcal genomes and genomic islands. Willem van Schaik
16:45 Virulence factors in enterococci. Cesar Arias
17:15 Biofilm formation: molecular bases and clinical implications. Helen Leavis
17:45 Discussion
Thursday, 19 November 2009
9:00 Mechanisms of resistance to quinolones. Jordi Vila
9:30 Mechanisms of resistance to vancomycin. Roland Leclercq
10:00 Linezolid: in vitro activity and antimicrobial resistance. John Quinn
10:30 Discussion
11:00 Coffee break
11:30 Animals as reservoirs for enterococci. Ole E. Heuer
12:00 Molecular typing of enterococci; emergence and spread of VRE in Europe. Guido Werner
12:30 Discussion
13:00 Lunch
15:00 Mobile genetic elements in enterococci. Teresa Coque
15:30 Population biology and ecology of Enterococcus faecium: from commensal to hospital-adapted pathogen. Rob Willems
16:00 The oxidative stress response of enterococci: connection to virulence and antibiotic resistance. Axel Hartke
16:30 Discussion
Friday, 20 November 2009
9:00 Changing epidemiology of enterococcal infections. Matteo Bassetti
9:30 Limitations of current recommendations of therapy of enterococcal endocarditis. Bruno Fantin
10:00 Beta-lactam combination in the treatment of enterococcal endocarditis. Javier Garau
10:30 Discussion
11:00 Coffee break
11:30 Post-genomic strategies to identify factors relevant for the in vivo lifestyle of E. faecalis. Pascale Serror
12:00 Enterococci and intra-abdominal infections. Stefanos Geroulanos
12:30 Role of Enterococcus spp in bone prosthetic infections. Andrej Trampuz
13:00 Discussion
13:30 Lunch
15:30 Role of enterococcal surface glycoconjugates in virulence and immune response. Johannes Hübner
16:00 New lipopeptides in the treatment of enterococcal infections. Rod Warren
17:00 Discussion
17:30 Closing remarks
